OPKO Health and Entera Bio, a developer of oral peptides and protein replacement therapies, entered into a license agreement ...

Under the terms of the agreement, OPKO will accept 60% of the development costs, while Entera will shoulder 40%.

Mounjaro, Eli Lilly's diabetes and obesity drug, is now available in India at a fraction of its US price. It offers treatment for weight loss and diabetes control, but watch out for the side effects ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

For months, I've spent my Saturdays speaking with a convicted killer, writes Anne Connolly. He says he's innocent, others ...

Examples of fast-acting carbohydrates include glucose tablets or gel ... and they will instead require an emergency dose of glucagon. This is a natural hormone that can help quickly raise blood ...

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...

It is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent ...

Davis had been there when Audrey Manuel's extremely low blood sugar reading was taken, and had even helped administer glucagon to try ... paracetamol and sleeping tablets. Davis told police ...